Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 18Breast Neoplasms 15Endometrial Neoplasms 11Uterine Cervical Neoplasms 5Carcinoma, Ovarian Epithelial 5Triple Negative Breast Neoplasms 4Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Neoplasms by Site 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Breast Diseases 3Uterine Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Hereditary Sensory and Autonomic Neuropathies 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urologic Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Sex Cord-Gonadal Stromal Tumors 1Sarcoma, Endometrial Stromal 1Sarcoma 1Recurrent Uterine Corpus Carcinoma 1Recurrence 1Pancreatic Neoplasms 1Liposarcoma 1Genital Neoplasms, Female 1

Interventions

pembrolizumab 5Carboplatin 4Nivolumab 3Cisplatin 3durvalumab 2Paclitaxel 2Immunohistochemistry 2Fluorouracil 2Bevacizumab 2tremelimumab 1toripalimab 1regorafenib 1obinutuzumab 1naptumomab estafenatox 1liposomal doxorubicin 1enzalutamide 1aflibercept 1abiraterone 1abemaciclib 1Ritonavir 1Polymerase Chain Reaction 1Oxaliplatin 1NEO212 1Mass Spectrometry 1Lopinavir 1Leucovorin 1Itraconazole 1Isotretinoin 1Ipilimumab 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Fulvestrant × Gynecologic × Clear all
NCT07109726 2026-05-22

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Terremoto Biosciences Inc.

Phase 1/2 Recruiting
205 enrolled
BreastGastrointestinalGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡